These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 17435940)

  • 1. Comments on "Weight gain management in patients with schizophrenia during treatment with olanzapine in association with nizatidine".
    Reis de Sá A; Elkis H
    Braz J Psychiatry; 2007 Mar; 29(1):90; author reply 91. PubMed ID: 17435940
    [No Abstract]   [Full Text] [Related]  

  • 2. Weight gain management in patients with schizophrenia during treatment with olanzapine in association with nizatidine.
    Assunção SS; Ruschel SI; Rosa Lde C; Campos JA; Alves MJ; Bracco OL; de Lima MS
    Braz J Psychiatry; 2006 Dec; 28(4):270-6. PubMed ID: 17242805
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nizatidine treatment and its relationship with leptin levels in patients with olanzapine-induced weight gain.
    Atmaca M; Kuloglu M; Tezcan E; Ustundag B
    Hum Psychopharmacol; 2003 Aug; 18(6):457-61. PubMed ID: 12923824
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of nizatidine on olanzapine-associated weight gain in schizophrenic patients in Korea: a pilot study.
    Pae CU; Kim JJ; Lee KU; Lee CU; Bahk WM; Lee SJ; Lee C; Paik IH
    Hum Psychopharmacol; 2003 Aug; 18(6):453-6. PubMed ID: 12923823
    [TBL] [Abstract][Full Text] [Related]  

  • 5. H(2) antagonist nizatidine may control olanzapine-associated weight gain in schizophrenic patients.
    Sacchetti E; Guarneri L; Bravi D
    Biol Psychiatry; 2000 Jul; 48(2):167-8. PubMed ID: 10903413
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nizatidine for prevention of weight gain with olanzapine: a double-blind placebo-controlled trial.
    Cavazzoni P; Tanaka Y; Roychowdhury SM; Breier A; Allison DB
    Eur Neuropsychopharmacol; 2003 Mar; 13(2):81-5. PubMed ID: 12650950
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of famotidine addition on olanzapine-induced weight gain in first-episode schizophrenia patients: a double-blind placebo-controlled pilot study.
    Poyurovsky M; Tal V; Maayan R; Gil-Ad I; Fuchs C; Weizman A
    Eur Neuropsychopharmacol; 2004 Aug; 14(4):332-6. PubMed ID: 15163444
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of betahistine, a histamine H1 receptor agonist/H3 antagonist, on olanzapine-induced weight gain in first-episode schizophrenia patients.
    Poyurovsky M; Pashinian A; Levi A; Weizman R; Weizman A
    Int Clin Psychopharmacol; 2005 Mar; 20(2):101-3. PubMed ID: 15729086
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of ranitidine in olanzapine-induced weight gain: a dose-response study.
    Mehta VS; Ram D
    Early Interv Psychiatry; 2016 Dec; 10(6):522-527. PubMed ID: 25529756
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HTR2C polymorphisms, olanzapine-induced weight gain and antipsychotic-induced metabolic syndrome in schizophrenia patients: a meta-analysis.
    Ma X; Maimaitirexiati T; Zhang R; Gui X; Zhang W; Xu G; Hu G
    Int J Psychiatry Clin Pract; 2014 Oct; 18(4):229-42. PubMed ID: 25152019
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Olanzapine metabolic side effects: a weight gain issue?
    Carulli L; Mazzi F; Rondinella S; Bertolotti M
    Intern Emerg Med; 2008 Sep; 3(3):237-40. PubMed ID: 18369533
    [No Abstract]   [Full Text] [Related]  

  • 12. Nizatidine for the treatment of patients with quetiapine-induced weight gain.
    Atmaca M; Kuloglu M; Tezcan E; Ustundag B; Kilic N
    Hum Psychopharmacol; 2004 Jan; 19(1):37-40. PubMed ID: 14716710
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predictors of antipsychotic-induced weight gain in first-episode psychosis: conclusions from a randomized, double-blind, controlled prospective study of olanzapine, risperidone, and haloperidol.
    Saddichha S; Ameen S; Akhtar S
    J Clin Psychopharmacol; 2008 Feb; 28(1):27-31. PubMed ID: 18204337
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Polymorphisms of the histamine receptor (H1HR) gene are not associated with olanzapine-induced weight gain.
    Godlewska BR; Olajossy-Hilkesberger L; Olajossy M; Limon J; Landowski J
    J Clin Psychopharmacol; 2013 Jun; 33(3):436-7. PubMed ID: 23609395
    [No Abstract]   [Full Text] [Related]  

  • 15. Hypertriglyceridemia associated with direct effects of olanzapine rather than with weight gain: a case report.
    Markham-Abedi C; de Leon J
    J Clin Psychiatry; 2006 Sep; 67(9):1473-4. PubMed ID: 17017841
    [No Abstract]   [Full Text] [Related]  

  • 16. Orally disintegrating olanzapine and potential differences in treatment-emergent weight gain.
    Karagianis J; Hoffmann VP; Arranz B; Treuer T; Maguire GA; de Haan L; Chawla B
    Hum Psychopharmacol; 2008 Jun; 23(4):275-81. PubMed ID: 18338426
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predictors and correlates for weight changes in patients co-treated with olanzapine and weight mitigating agents; a post-hoc analysis.
    Stauffer VL; Lipkovich I; Hoffmann VP; Heinloth AN; McGregor HS; Kinon BJ
    BMC Psychiatry; 2009 Mar; 9():12. PubMed ID: 19327167
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacogenomic associations with weight gain in olanzapine treatment of patients without schizophrenia.
    Houston JP; Kohler J; Bishop JR; Ellingrod VL; Ostbye KM; Zhao F; Conley RR; Poole Hoffmann V; Fijal BA
    J Clin Psychiatry; 2012 Aug; 73(8):1077-86. PubMed ID: 22967772
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metformin addition attenuates olanzapine-induced weight gain in drug-naive first-episode schizophrenia patients: a double-blind, placebo-controlled study.
    Wu RR; Zhao JP; Guo XF; He YQ; Fang MS; Guo WB; Chen JD; Li LH
    Am J Psychiatry; 2008 Mar; 165(3):352-8. PubMed ID: 18245179
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acute weight gain, gender, and therapeutic response to antipsychotics in the treatment of patients with schizophrenia.
    Ascher-Svanum H; Stensland M; Zhao Z; Kinon BJ
    BMC Psychiatry; 2005 Jan; 5():3. PubMed ID: 15649317
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.